Ganglioside GM1 IgM Antibody, Serum, Qualitative

What Is Being Tested

The test looks for a type of antibody called immunoglobulin M (IgM) that binds to GM1 ganglioside. Gangliosides are fatty molecules that are abundant on the outer surface of nerve cells, especially in the peripheral nervous system. Finding these antibodies in the blood can be a clue that the immune system is mistakenly targeting nerve tissue.

Why Your Doctor May Order This Test

Doctors often order this test when someone has progressive weakness, tingling, numbness, or other nerve symptoms that might suggest an immune-related neuropathy. It is most commonly used to help evaluate Guillain-Barre syndrome and a chronic condition called multifocal motor neuropathy. Results are never used alone; they are combined with the physical exam, nerve studies, and other laboratory findings.

How the Test Is Performed

A small sample of blood is collected from a vein, usually in your arm, and sent to a specialized laboratory. There, a technique called immunoassay is used to detect whether GM1 IgM antibodies are present. The result is typically reported as positive or negative, sometimes with a titer or level, but the report wording varies by laboratory.

What the Result Means

A negative result means these specific antibodies were not detected. A positive result means they were found, which can support certain nerve diagnoses but does not prove them on its own. Some people without nerve disease can have low levels of these antibodies, and some people with nerve disease do not have them. Your doctor will explain what your result means in the context of your symptoms and other tests.